Status: Not yet recruiting

1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss

To evaluate the efficacy of either a 1550nm non-ablative fractional laser or a 1927nm thulium fractional laser in the treatment of female pattern hair loss (FPHL).

Participants needed: 10

Trial details

Age: 35-65Biological sex: FemaleType: InterventionalSponsor: Goldman, Butterwick, Fitzpatrick and GroffUpdated: Apr 16, 2025Locations: 1

Eligibility criteria

Adult women aged 35-65 years [+17]

No surgery, pregnancy, breast feeding, change in or addition of hormonal contrac... [+16]

Status: Not yet recruiting

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

The primary objective of the study is to assess the safety and efficacy of DA-005 and DA-002 as a treatment for hair loss (androgenetic alopecia).

Participants needed: 516

Trial details

Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Applied Biology, Inc.Updated: Dec 19, 2024

Eligibility criteria

Age 18 or older [+4]

A medical history that may interfere with study objectives [+7]

Status: Not yet recruiting

Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss

The goal of this clinical trial is to evaluate the efficacy and safety of OMA102 1 mg and OMA102 2 mg versus placebo in the treatment of female pattern hair loss.

Participants needed: 504

Trial details

Phase: Phase 3Age: 18-50Biological sex: FemaleType: InterventionalSponsor: EMSUpdated: Feb 16, 2024Locations: 1

Eligibility criteria

Ability to confirm voluntary participation and agree to all trial purposes by si... [+3]

Any clinical or physical finding interpreted by the investigator as a risk to su... [+22]

Female Pattern Baldness

1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss